Hyperlipidemia Combined
1 clinical trials · Condition
◉ Watch Hyperlipidemia Combined
| Record | Firm | Date |
|---|---|---|
| A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome (NCT00349284) | Solvay Pharmaceuticals | 2005-01-01 |
Track Hyperlipidemia Combined automatically
Every clearance here is in the API, with alerts when new ones post.